Lykos Therapeutics

FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment

Veterans Affairs Eyes Funding For New MDMA-PTSD Trial After FDA Setback

MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?

Veterans Affairs Eyes Funding For New MDMA-PTSD Trial After FDA Setback

MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?

Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down

Lykos Therapeutics Strategic Reorganization Following FDA's Decision Rejecting MDMA For PTSD Treatment

Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down

Lykos Therapeutics Strategic Reorganization Following FDA's Decision Rejecting MDMA For PTSD Treatment

MDMA Therapy Papers Retracted Amid Ethical Concerns At Lykos Study Site

FDA Rejects MDMA For PTSD Treatment, Calls For More Research On Psychedelic Therapy

Lykos Therapeutics Recent News

FDA Poised To Make Historic Decision On MDMA Therapy To Treat PTSD: Here's How Things Stand

The FDA is set to decide on MDMA therapy for PTSD, a move that could revolutionize treatment for veterans and others with severe trauma. Here's what's at stake

Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles

A new review finds MDMA therapy for PTSD promising but calls for more research before widespread adoption. Lawmakers urge FDA to reconsider its decision.

MDMA Therapy For PTSD Closer To Legality As Key FDA Approval Meeting Approaches, Sparking Hope And Controversy

MDMA nears FDA approval for PTSD treatment, sparking hope and controversy. Read now about its potential impact and the challenges ahead.